Shopping Cart
Remove All
Your shopping cart is currently empty
AS1708727 is an orally bioavailable FOXO1 inhibitor that reduces plasma glucose and triglyceride levels in diabetic mice.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $297 | 6-8 weeks | 6-8 weeks | |
| 25 mg | $916 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,190 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $1,860 | 6-8 weeks | 6-8 weeks |
| Description | AS1708727 is an orally bioavailable FOXO1 inhibitor that reduces plasma glucose and triglyceride levels in diabetic mice. |
| In vitro | AS1708727 inhibits hepatic gluconeogenic gene expression and suppresses elevated blood glucose levels [1]. |
| In vivo | AS1708727 (30-300 mg/kg; oral) reduces plasma glucose and triglyceride levels in diabetic db/db mice, exhibiting antidiabetic activity [1]. |
| Synonyms | AS-1708727, AS 1708727 |
| Molecular Weight | 443.37 |
| Formula | C24H24Cl2N2O2 |
| Cas No. | 1253226-93-5 |
| Smiles | O=C(N(C1=CC=C(Cl)C(=C1Cl)COC2=CC=CC=3C=NC=CC23)C)CC4CCCC4 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 32 mg/mL (72.17 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.